PBMCs from CRMO patients obtained during the active disease expressed higher mRNA levels of inflammasome key components, ASC and CASP-1, and higher levels of IL-1β mRNA. The gene discussed is CASP1; the disease is chronic recurrent multifocal osteomyelitis.